Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2026

Antidilutive Securities Excluded from Computation of Earnings Per Share

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:


	March 31, 2026	March 31, 2025
	(shares)	(shares)
Warrants to purchase shares of common stock	4,172,144	9,595,777
Options to purchase shares of common stock	7,207,593	7,999,758
Restricted stock units	518,158	536,520
Shares of common stock issuable upon conversion of convertible notes payable – related party	7,785,092	7,175,772
Shares of common stock issuable upon conversion of convertible line of credit – related party	33,642,982	25,515,956
Shares of common stock issuable upon conversion of preferred stock	490,840	499,174
	53,816,809	51,322,957